77
Views
9
CrossRef citations to date
0
Altmetric
Perspective

New vaccines against enteric bacteria for children in less developed countries

Pages 807-812 | Published online: 09 Jan 2014

References

  • Lagos R, Fasano A, Wasserman SS et al. Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR. J. Infect. Dis. 180, 1709–1712 (1999).
  • Walker RI, Van De Verg LL, Hall R, Schmitt CK, Woo K, Hale V. Enteric vaccines for pediatric use. Workshop summary. Vaccine 23, 5432–5439 (2005).
  • Cooper PJ, Chico ME, Losonsky G. Albendazole® treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated cholera vaccine CVD 103-HgR. J. Infect. Dis. 182, 1199–1206 (2000).
  • Qadri F, Svennerholm AM, Faruque ASG, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin. Microbiol. Rev. 18, 465–483 (2005).
  • Svennerholm AM, Steele D. Progress in enteric vaccine development. Best Practice Res.Clin. Gastroenterol. 18, 421–445 (2004).
  • Walker RI. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries. Vaccine 23, 3369–3385 (2005).
  • Boedeker EC. Vaccines for enterotoxigenic Eschericia coli: current status. Curr. Opin. Gastroenterol. 21, 15–19 (2005).
  • Svennerholm AM, Savarino SJ. Oral Inactivated Whole Cell B Subunit Combination Vaccine Against Enterotoxigenic Escherichia coli, 3rd Ed. Marcel Decker, NY, USA. (2004).
  • Noriega FR, Liao FM, Maneval DR, Ren S, Formal SB, Levine MM. Strategy for cross-protection among Shigella flexneri serotypes. Infect. Immun. 67, 782–788 (1999).
  • Lucas ME, Deen JL, von Seidlein L et al. Effectivness of mass oral cholera vaccination in Beira, Mozambique. N. Eng. J. Med. 352, 757–767 (2005).
  • Ali M, Emch M, von Seidlein L et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh. Lancet 366, 44–49 (2005).
  • McKenzie R, Walker RI, Nabors GS et al. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial. Vaccine (2005) (In Press).
  • Byce J, Boschi-Pinto C, Shibuya K, Black RE, WHO Child Health Epidemiology Reference Group.WHO estimates of the causes of death in children. Lancet 365, 1147–1152 (2005).
  • Guerrant RL, Schorling JB, McAuliffe JF, De Souza MA. Diarrhea as a cause and effect of malnutrition: diarrhea prevents catch-up growth and malnutrition increases diarrhea frequency and duration. Am. J. Trop. Med. Hyg. 47, 28–35 (1992).
  • Guerrant RL, Kosek M, Moore S, Lorentz B, Brantley R, Lima AA. Magnitude and impact of diarrheal diseases. Arch. Med. Res. 33, 351–355 (2002).

Website

  • The Diseases of the Most Impoverished (DOMI). www.ivi.org (Accessed November 2005)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.